Reference
- Aduma P., Connelly M., Srinivas R. V., Fridland A. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates. Mol Pharmacol 1995; 47: 816–822
- Andrei G., Snoeck R., Vandeputte M., De Clercq E. Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemother 1997; 41: 587–593
- Assouline J., Major E. Human fetal Schwann cells support JC virus multiplication. J Virol 1991; 65: 1002–1006
- Berger R. J., Majur E. O. Progressive multifocal Leukoencephalopathy. Textbook at AIDS medicine, S Broder, T Merigan, D Bolognesi. Williams and Wilkins, Baltimore, MDUSA 1994; 385–400
- Berger J. R., Mucke L. Prolonged survival and partial recovery in AIDS associated progressive multifocal leukoencephalopathy. Neurology 1988; 38: 1060–1065
- Berger J. R., Concha M. Progressive multifocal leukoencephalopatiry: the evolution of a disease once considered rare. J Neurovirol 1995; 1: 5–18
- Blick G., Whiteside M., Griegor P., Hopkins U., Garton T., Lagravinese L. Successful resolution of progressive multifocal leukoencephalopathy after combination therapy with cidofovir and cytosine arabinoside. Clin Infect Dis 1998; 26: 191–192
- Brooks B. R., Walker D. L. Progressive multifocal leukoencephalopathy. Neurol Clin 1984; 2: 299–313
- Budka H., Shah K. Papovavirus antigens in paraffin sections of PML brains. Polyomaviruses and Human Neurological Disease, J Sever, D Madday. Alan R Liss, NY 1983; 299–309
- Conway B., Halliday W. C., Bmnham R. C. Human immunodeficiency virus-associated progressive multifocal leukoencephalopathy: apparent response to 3′-azido-3′-deoxythymidine. Rev Infect Dis 1990; 12: 479–482
- Frye S., Trebst C., Dittmer U., Petry M., Bodemer M., Hunsamann G., Weber T., Luke W. Efficient production of JC virus in SVG cells and the use of purified viral antigens for analysis of specific humoral and cellular immune response. J Virol Methods 1997; 63: 81–92
- Groothuis D. R., Levy R. M. The entry of antiviral and antiretroviral drugs into the central nervous system. J Neurovirol 1997; 3: 387–400
- Hall C. D., Dafni U., Simpson D., Clifford D., Wetherill P. E., Cohen B., Mcarthur J., Hollander H., Yainnoutsos C., Major E. O., Millar L., Timpone J. The ACTG 243 team failure of cytarabine in Progressive Multifocal Leukoencephalopathy associated with human immunodeficiency virus defections. New England Journal of Medicine 1998; 338: 1345–1351
- Heilbronn R., Albrecht I., Stephan S., Burkle A., Zur Hausen H. Human cytomegalovirus induces JC virus DNA replication in human fibroblasts. Proc Natl Acad Sci USA 1993; 90: 11406–11410
- Itoyama Y., Webster H., Sternberger N. H., Richardson E. P., Walker D. L., Quarles R. H., Padgett B. L. Distribution of papovavirus, myelin-associated glycoprotein and myelin basic protein in progressive multifocal leukoencephalopathy lesions. Ann Neurol 1982; 11: 369–407
- Kerr D. A., Chang C. F., Gordon J., Bjornsti M. A., Khalili K. Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin. Virology 1993; 196: 612–618
- Levy R. M., Ward S., Schalgeter K., Groothuis D. Alternative delivery systems for antiviral nucleosides and antisense oligonucleotides to tie brain. J Neurovirol 1997; 3: S74–S75, Supp 1
- Major E. O., Miller A. E., Morrain P., Traub R. G., Dewidt E., Sever J. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc Natl Acad Sci USA 1985; 82: 1257–1261
- Major E. O., Amemiya K., Tornatore C. S., Houf S. A., Berger J. R. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus induced demyelinating disease of tie human brain. Clin Microbiol Rev 1992; 5: 49–73
- Major E. O., Ault G. Progressive multifocal leukoencephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunodeficient patient. Curr Opp Neurol 1995; 8: 184–190
- Major E. O., Curfman B. L. Viral-induced demyelina-tion leading to progressive multifocal leukoencephalopathy: the involvement of both immune and nervous system target cells. Defense of the Brain, I Remington, P Peterson. Blackwell Sciences, Boston, MA 1997; 305–321
- Marriot P. J., O'Brien M. D., Mackenzie I. C., Janota I. Progressive multifocal leukoencephalopathy: remission with cytarabine. J Neurol Neurosurg Psychiatry 1975; 38: 205–209
- Melton S. T., Kirkwood C. K., Ghaemi S. N. Pharmacotherapy of HIV dementia. Ann Pharmacotherapy 1997; 31: 457–472
- Monaco M. C., Atwood W. J., Gravell M., Tornatore C. S., Major E. O. JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency. J Virol 1996; 70: 7004–7012
- O'Riordan T., Daly P. A., Hutchinson M., Shattock A. G., Gardner S. D. Progressive multifocal leukoence-phalopathy-remission with cytarabine. J Infect Dis 1990; 20: 51–54
- Padgett B. L., Walker D. Virologic and serologic studies of progressive multifocal leukoencephalopathy. Prog Clin Biol Res 1983; 105: 107–117
- Portegies P., Algra P. R., Hollar C.E.M, Prins J. M., Reiss P., Vlak J., Lange J. Response to cytarabine in progressive multifocal leukoencephalopathy in AIDS. Lancet 1991; 337: 680–681